Budget Impact of Strategies Involving RSVpreF and Nirsevimab to Protect Infants in Saudi Arabia Against Respiratory Syncytial Virus.
Saved in:
| Title: | Budget Impact of Strategies Involving RSVpreF and Nirsevimab to Protect Infants in Saudi Arabia Against Respiratory Syncytial Virus. |
|---|---|
| Authors: | Alharbi AS; Department of Pediatrics, Prince Sultan Military Medical City, 12233, Riyadh, Saudi Arabia., Abu-Shraie N; King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, 11426, Riyadh, Saudi Arabia., Al Abdulkarim H; King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, 11426, Riyadh, Saudi Arabia., Alharbi IH; King Fahad Armed Forces Hospital, 23311, Jeddah, Saudi Arabia., Averin A; Avalere Health, Washington, DC, 20005, USA., Law AW; Pfizer Inc., New York, NY, 10001, USA., Mendes D; Pfizer Ltd., Tadworth, Surrey, KT20 7NS, UK., Quinn E; Avalere Health, Washington, DC, 20005, USA., Zayed M; Pfizer Gulf FZ LLC, Atlas Group Management Building, 5th Floor, Dubai Media City, Dubai, United Arab Emirates. Mostafa.Zayed@pfizer.com., Behiry A; Pfizer Scientific Technical Limited Company, 13519, Riyadh, Saudi Arabia., Haridy H; Pfizer Gulf FZ LLC, Atlas Group Management Building, 5th Floor, Dubai Media City, Dubai, United Arab Emirates., Mousa M; Pfizer Scientific Technical Limited Company, 13519, Riyadh, Saudi Arabia. |
| Source: | Infectious diseases and therapy [Infect Dis Ther] 2026 Jun 17. Date of Electronic Publication: 2026 Jun 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42307865 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Budget Impact of Strategies Involving RSVpreF and Nirsevimab to Protect Infants in Saudi Arabia Against Respiratory Syncytial Virus. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Alharbi+AS%22">Alharbi AS</searchLink>; Department of Pediatrics, Prince Sultan Military Medical City, 12233, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Abu-Shraie+N%22">Abu-Shraie N</searchLink>; King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, 11426, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Al+Abdulkarim+H%22">Al Abdulkarim H</searchLink>; King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, 11426, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Alharbi+IH%22">Alharbi IH</searchLink>; King Fahad Armed Forces Hospital, 23311, Jeddah, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Averin+A%22">Averin A</searchLink>; Avalere Health, Washington, DC, 20005, USA.<br /><searchLink fieldCode="AU" term="%22Law+AW%22">Law AW</searchLink>; Pfizer Inc., New York, NY, 10001, USA.<br /><searchLink fieldCode="AU" term="%22Mendes+D%22">Mendes D</searchLink>; Pfizer Ltd., Tadworth, Surrey, KT20 7NS, UK.<br /><searchLink fieldCode="AU" term="%22Quinn+E%22">Quinn E</searchLink>; Avalere Health, Washington, DC, 20005, USA.<br /><searchLink fieldCode="AU" term="%22Zayed+M%22">Zayed M</searchLink>; Pfizer Gulf FZ LLC, Atlas Group Management Building, 5th Floor, Dubai Media City, Dubai, United Arab Emirates. Mostafa.Zayed@pfizer.com.<br /><searchLink fieldCode="AU" term="%22Behiry+A%22">Behiry A</searchLink>; Pfizer Scientific Technical Limited Company, 13519, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Haridy+H%22">Haridy H</searchLink>; Pfizer Gulf FZ LLC, Atlas Group Management Building, 5th Floor, Dubai Media City, Dubai, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Mousa+M%22">Mousa M</searchLink>; Pfizer Scientific Technical Limited Company, 13519, Riyadh, Saudi Arabia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101634499%22">Infectious diseases and therapy</searchLink> [Infect Dis Ther] 2026 Jun 17. <i>Date of Electronic Publication: </i>2026 Jun 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%22">Adis </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101634499 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8229 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221936382%22">21936382 </searchLink><i>NLM ISO Abbreviation: </i>Infect Dis Ther |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42307865 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40121-026-01386-5 Languages: – Code: eng Text: English Titles: – TitleFull: Budget Impact of Strategies Involving RSVpreF and Nirsevimab to Protect Infants in Saudi Arabia Against Respiratory Syncytial Virus. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Alharbi AS – PersonEntity: Name: NameFull: Abu-Shraie N – PersonEntity: Name: NameFull: Al Abdulkarim H – PersonEntity: Name: NameFull: Alharbi IH – PersonEntity: Name: NameFull: Averin A – PersonEntity: Name: NameFull: Law AW – PersonEntity: Name: NameFull: Mendes D – PersonEntity: Name: NameFull: Quinn E – PersonEntity: Name: NameFull: Zayed M – PersonEntity: Name: NameFull: Behiry A – PersonEntity: Name: NameFull: Haridy H – PersonEntity: Name: NameFull: Mousa M IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 06 Text: 2026 Jun 17 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2193-8229 Titles: – TitleFull: Infectious diseases and therapy Type: main |
| ResultId | 1 |
